In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Abgenix and Chugai collaborate on antibody therapeutics
Abgenix and Genentech Extend Antibody Technology Licensing Agreement
Cellomics Delivers First Kinetic High Content Screening Platform
Abgenix to trial human monoclonal antibody in cancer patients
Abgenix to receive milestone payment from Pfizer
Lexicon delivers novel antigens to Abgenix
Abgenix and CuraGen agree development alliance
Antibody collaboration agreed by Abgenix and Immunex